Lodrane D (Brompheniramine maleate 4 mg and Pseudoephedrine HCl 60 mg) Capsules, 60-count bottles, Distributed by: Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807, UPC 0 00950 86006 8.

Class I - Dangerous

What Should You Do?

  1. Check if you have this product:
    Lot #'s P0230-022R, P0230-023R, Exp 06/17
  2. Do not eat it: Even if it looks and smells fine, do not consume this product.
  3. Throw it away or return it: You can return the product to the store for a full refund.
  4. Seek medical attention if needed: If you've consumed this product and feel unwell, contact your doctor immediately.
  5. Report problems: Report any issues to the FDA's Safety Reporting Portal.

⚠️ Emergency: If you experience severe symptoms after consuming this product, call 911 or Poison Control at 1-800-222-1222.

Recall Details

Company:
Valeant Pharmaceuticals North America LLC
Reason for Recall:
Labeling: Not Elsewhere Classified: correctly labeled bottles were packaged in cartons that were mislabeled with an incorrect active ingredient, phenylephrine rather than pseudoephedrine, on the carton face and carton top.
Classification:
Class I - Dangerous

Dangerous or defective products that predictably could cause serious health problems or death.

Status:
terminated

Product Information

Full Description:

Lodrane D (Brompheniramine maleate 4 mg and Pseudoephedrine HCl 60 mg) Capsules, 60-count bottles, Distributed by: Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807, UPC 0 00950 86006 8.

Product Codes/Lot Numbers:

Lot #'s P0230-022R, P0230-023R, Exp 06/17

Official Source

Always verify recall information with the official FDA source:

View on FDA.gov

FDA Recall Number: D-1032-2016

Related Recalls

Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points.

Jan 30, 2019 Prescription Drugs Nationwide View Details →

Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points.

Jan 30, 2019 Prescription Drugs Nationwide View Details →

Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points.

Jan 30, 2019 Prescription Drugs Nationwide View Details →